BACKGROUND
Late-onset multiple sclerosis (LOMS), defined as disease onset at or after 50 years, is increasingly recognized and associated with distinct features. However, it remains unclear whether LOMS differs etiologically from adult-onset multiple sclerosis (AOMS).
OBJECTIVES
To determine whether established MS risk factors differ between LOMS and AOMS and influence age at onset.
METHODS
We conducted a Swedish population-based case-control study including 3950 incident MS cases and 7340 controls. Cases were classified as LOMS (n = 396) or AOMS (n = 3554). Associations between risk factors and LOMS and AOMS were estimated using logistic regression. Case-only analyses assessed associations with age at onset.
RESULTS
Most MS risk factors, including MS heredity, HLA-DRB1*15:01, Epstein-Barr nuclear antigen (EBNA)-1 antibody levels, smoking, and low sun exposure, were associated with both onset groups, with stronger effects in AOMS. Elevated body mass index at age 20 years was associated with AOMS, while estimates in LOMS were imprecise. Case-only analyses showed no association with disease timing. Exposure distribution varied across birth cohorts, suggesting cohort effects.
CONCLUSION
Established MS risk factors appear to be more clearly related to disease susceptibility than to timing of onset. The broadly consistent risk factor profiles support a shared etiology, although modest differences cannot be excluded.
V. Karrenbauer, Tomas Olsson, L. Alfredsson et al.· Multiple Sclerosis· 0 citations
Analysis of a markedly larger, higher-coverage, and geographically diverse whole-genome sequencing dataset from 529 ancient individuals sheds important light on the demographic impact of major sociohistorical changes that occurred during the late Medieval period in Scandinavia and the Baltic region and link Christianisation to increased diversity in ancestry before the pandemic.
Xiaodong Liu, K. Moore, S. Ebenesersdóttir et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.